BioSpace News Archive

Thomas Scientific has finalized a five-year contract with Florida State University (FSU) as a strategic supplier of laboratory products and services.

Reven Holdings, Inc. today announced the publication of a peer-reviewed article in the prestigious medical journal Frontiers in Oncology.

Delcath Systems, Inc. announced today it will host a comprehensive Investor Update event on Thursday, December 2 nd , from 10:00am ET – 1:00pm ET.

The increased health consciousness among people leads to the demand for smart devices to monitor their health records.

One of the popular methods of crime detection is the use of forensics technology. The rising influence of forensic technologies in various crime investigation scenarios will present an array of opportunities for the forensic technologies market during the forecast period of 2017-2025.

Pfizer Inc. announced its investigational novel COVID-19 oral antiviral candidate, PAXLOVID™, significantly reduced hospitalization and death, based on an interim analysis of the Phase 2/3 EPIC-HR randomized, double-blind study of non-hospitalized adult patients with COVID-19, who are at high risk of progressing to severe illness.

Nabriva Therapeutics plc today announced that Ted Schroeder, Chief Executive Officer at Nabriva, will provide a company overview and business update at the Jefferies London Healthcare Conference.

Calithera Biosciences, Inc. today announces the promotion of current vice president and head of clinical development, Dr. Emil T. Kuriakose, to chief medical officer (CMO).

Omeros Corporation (Nasdaq: OMER) today announced results of long-term follow-up from the Phase 2 clinical trial evaluating its MASP-2 inhibitor narsoplimab in patients with IgA nephropathy.

BriaCell Therapeutics Corp. announces the addition of Suzanne Ostrand-Rosenberg, Ph.D. to its Scientific Advisory Board.